Lexicon Pharmaceuticals
LXRX
#6646
Rank
ยฃ0.62 B
Marketcap
ยฃ1.41
Share price
0.54%
Change (1 day)
18.92%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -ยฃ0.11

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.11. In 2025 the company made an earnings per share (EPS) of -ยฃ0.11 an increase over its 2024 EPS that were of -ยฃ0.48.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.11-0.43%
2025-ยฃ0.11-78.13%
2024-ยฃ0.48-20%
2023-ยฃ0.6031.15%
2022-ยฃ0.46-0%
2021-ยฃ0.4610.91%
2020-ยฃ0.41-145.08%
2019ยฃ0.92-206.09%
2018-ยฃ0.87-5.74%
2017-ยฃ0.92-10.95%
2016-ยฃ1.032640%
2015-ยฃ0.03771-96.34%
2014-ยฃ1.03-2.53%
2013-ยฃ1.06-9.09%
2012-ยฃ1.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ14.32-13,664.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ4.44-4,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ35.44-33,657.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ3.91 3,607.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ1.95-1,950.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.01509-85.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.57 435.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-ยฃ0.06789-35.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ22.09 20,821.43%๐Ÿ‡บ๐Ÿ‡ธ USA